Kovai Medical Center & Hospital Ltd

Kovai Medical Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Kovai Medical Center & Hospital Ltd

₹ 5,273 -1.17%
21 Nov 4:00 p.m.
kmchhospitals.com BSE: 523323 NSE: KOVAI
About

Kovai Medical Center & Hospital Ltd is a Coimbatore-based company which is in the business of advanced healthcare services. It also forayed into education services in 2019 with the commencement of its new Medical College in Coimbatore.[1]

Key Points

Hospital Portfolio
The company operates peripheral centers in Coimbatore, Sulur, Coimbatore (city center), Erode, and Kovilpalayam, along with hospitals having a combined capacity of approximately 2250 beds. [1]

Website BSE NSE
  • Market Cap ₹ 5,769 Cr.
  • Current Price ₹ 5,273
  • High / Low ₹ 5,770 / 3,050
  • Stock P/E 28.6
  • Book Value ₹ 890
  • Dividend Yield 0.19 %
  • ROCE 22.6 %
  • ROE 22.4 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company has delivered good profit growth of 24.5% CAGR over last 5 years

Cons

  • Company might be capitalizing the interest cost

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Healthcare Industry: Healthcare

Part of BSE Allcap BSE SmallCap BSE Healthcare

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024
218 229 220 236 252 264 267 275 303 321 321 315 344
154 165 166 174 184 193 200 206 217 225 229 229 248
Operating Profit 64 64 54 62 68 71 67 68 85 96 92 86 96
OPM % 29% 28% 25% 26% 27% 27% 25% 25% 28% 30% 29% 27% 28%
2 4 3 4 3 4 5 6 4 5 6 5 5
Interest 11 11 10 10 10 10 10 10 8 7 7 7 8
Depreciation 23 22 21 23 22 22 22 22 23 23 24 24 24
Profit before tax 32 36 26 32 39 43 41 42 58 71 67 61 67
Tax % 25% 27% 28% 27% 23% 27% 25% 26% 26% 25% 22% 25% 25%
24 26 19 24 30 31 31 31 43 53 52 46 51
EPS in Rs 22.07 23.82 17.20 21.74 27.67 28.46 27.93 28.38 39.67 48.53 47.69 41.81 46.32
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 TTM
297 334 402 465 531 588 628 712 690 905 1,020 1,220 1,301
227 261 307 374 406 459 494 540 495 645 746 874 932
Operating Profit 70 73 94 92 125 129 135 171 195 261 274 346 370
OPM % 24% 22% 23% 20% 23% 22% 21% 24% 28% 29% 27% 28% 28%
3 5 7 8 6 7 8 10 12 12 14 21 20
Interest 27 24 20 17 15 13 15 18 33 46 43 37 29
Depreciation 15 16 21 21 24 34 36 52 68 85 89 92 95
Profit before tax 31 37 59 62 92 89 93 112 106 141 155 238 266
Tax % 32% 36% 35% 35% 35% 35% 35% 15% 27% 26% 25% 24%
21 24 39 40 60 58 60 95 78 104 116 180 202
EPS in Rs 19.42 21.68 35.37 36.95 54.81 52.99 54.96 86.44 71.00 95.28 105.80 164.25 184.35
Dividend Payout % 8% 7% 4% 7% 5% 6% 5% 3% 4% 6% 9% 6%
Compounded Sales Growth
10 Years: 14%
5 Years: 14%
3 Years: 21%
TTM: 17%
Compounded Profit Growth
10 Years: 22%
5 Years: 25%
3 Years: 32%
TTM: 48%
Stock Price CAGR
10 Years: 27%
5 Years: 46%
3 Years: 48%
1 Year: 64%
Return on Equity
10 Years: 21%
5 Years: 20%
3 Years: 20%
Last Year: 22%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Sep 2024
Equity Capital 11 11 11 11 11 11 11 11 11 11 11 11 11
Reserves 70 91 127 165 224 276 332 420 499 598 708 878 963
209 184 163 158 125 202 378 543 623 550 511 310 420
55 65 85 96 103 116 129 134 148 184 209 240 252
Total Liabilities 345 351 386 430 464 605 850 1,108 1,281 1,343 1,439 1,439 1,645
279 277 281 337 354 443 469 643 1,033 1,085 1,088 1,118 1,102
CWIP 5 5 17 10 6 13 227 300 45 5 23 39 68
Investments 4 4 4 4 4 0 0 0 0 0 0 0 0
57 65 85 78 100 149 153 165 203 253 328 282 475
Total Assets 345 351 386 430 464 605 850 1,108 1,281 1,343 1,439 1,439 1,645

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
62 68 97 85 99 87 126 166 186 262 263 344
-9 -12 -80 -113 -83 -192 -352 -349 -180 -292 -358 -290
-48 -52 -43 -24 -50 60 160 113 38 -119 -86 -243
Net Cash Flow 6 4 -26 -53 -33 -45 -66 -70 44 -149 -180 -189

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Debtor Days 5 8 9 7 8 8 6 4 7 8 8 5
Inventory Days 35 33 25 22 20 23 20 23 19 19 18 17
Days Payable 29 35 53 47 37 43 47 46 29 20 35 30
Cash Conversion Cycle 11 6 -19 -19 -9 -12 -21 -19 -2 6 -9 -7
Working Capital Days -49 -43 -56 -52 -47 -48 -49 -36 -38 -38 -38 -42
ROCE % 20% 21% 27% 25% 31% 24% 18% 15% 13% 16% 17% 23%

Shareholding Pattern

Numbers in percentages

1 Recently
Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
55.74% 55.71% 55.76% 55.76% 55.76% 55.98% 56.26% 56.43% 56.44% 56.47% 56.50% 56.51%
2.09% 2.13% 2.12% 2.14% 2.15% 2.18% 2.20% 2.25% 2.24% 0.34% 0.32% 0.44%
1.77% 1.95% 1.95% 1.92% 1.97% 2.07% 2.19% 2.09% 2.09% 4.18% 4.28% 4.37%
40.40% 40.21% 40.17% 40.19% 40.12% 39.79% 39.34% 39.24% 39.24% 39.02% 38.91% 38.67%
No. of Shareholders 9,5179,6889,5599,5449,4649,67410,48710,73010,33811,91813,14714,800

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Credit ratings